Dren Bio
Dren Bio develops antibody therapies for cancer, autoimmune conditions and other serious diseases.
$350MPrivate financing
ParticipantActivity from announced rounds
Dren Bio develops antibody therapies for cancer, autoimmune conditions and other serious diseases.
Develops in vivo engineered monocyte immunotherapy to treat solid tumours in preclinical stage
STORM Therapeutics develops cancer medicines that target enzymes responsible for chemical modifications to RNA.
Crossbow Therapeutics develops antibody therapies for cancer.
Develops bispecific antibodies for targeted degradation of extracellular proteins.